Menu
GeneBe

GBP3

guanylate binding protein 3, the group of Guanylate binding proteins

Basic information

Region (hg38): 1:89006678-89022894

Links

ENSG00000117226NCBI:2635OMIM:600413HGNC:4184Uniprot:Q9H0R5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GBP3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GBP3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
25
clinvar
3
clinvar
1
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 25 3 1

Variants in GBP3

This is a list of pathogenic ClinVar variants found in the GBP3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-89007764-T-A not specified Uncertain significance (Dec 03, 2021)2401693
1-89007770-A-G Benign (May 01, 2023)2638916
1-89007842-C-A not specified Uncertain significance (Feb 05, 2024)3098896
1-89009043-A-T not specified Uncertain significance (Dec 14, 2023)3098895
1-89009055-C-G not specified Uncertain significance (Dec 20, 2021)2359479
1-89009134-C-T not specified Uncertain significance (Dec 16, 2022)2336208
1-89010998-C-T not specified Uncertain significance (Jun 18, 2021)2357143
1-89011105-G-T not specified Likely benign (Oct 03, 2022)2387890
1-89011887-T-C not specified Uncertain significance (Jan 31, 2024)3098894
1-89011923-C-T not specified Uncertain significance (May 09, 2023)2541678
1-89011928-G-A not specified Uncertain significance (Nov 22, 2023)3098900
1-89011936-T-C not specified Uncertain significance (Mar 21, 2023)2516615
1-89011965-C-T not specified Uncertain significance (Mar 11, 2022)2359077
1-89013259-G-A not specified Uncertain significance (May 26, 2022)2291060
1-89013296-C-G not specified Uncertain significance (Oct 20, 2023)3098899
1-89013317-C-T not specified Uncertain significance (Jun 16, 2024)3280931
1-89013328-C-T not specified Uncertain significance (Jun 24, 2022)2412216
1-89013329-G-A not specified Likely benign (Aug 02, 2021)2211591
1-89013343-T-C not specified Uncertain significance (May 09, 2023)2544457
1-89013379-C-T not specified Likely benign (Dec 05, 2022)2360050
1-89013389-G-A not specified Uncertain significance (Jul 25, 2023)2613632
1-89014110-G-C not specified Uncertain significance (Apr 28, 2022)2286673
1-89014548-A-G not specified Likely benign (Mar 25, 2024)3280933
1-89014623-G-C not specified Uncertain significance (Oct 27, 2023)3098897
1-89014656-C-T not specified Uncertain significance (Sep 15, 2021)2219270

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GBP3protein_codingprotein_codingENST00000370481 1016229
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.03e-180.00466125184285361257480.00225
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.03753053031.010.00001523912
Missense in Polyphen6472.9040.877871019
Synonymous0.7401081180.9130.000006211105
Loss of Function0.1092828.60.9780.00000156335

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.03100.0296
Ashkenazi Jewish0.000.00
East Asian0.0002170.000217
Finnish0.00004620.0000462
European (Non-Finnish)0.0004940.000431
Middle Eastern0.0002170.000217
South Asian0.0003020.000294
Other0.001200.000978

dbNSFP

Source: dbNSFP

Function
FUNCTION: Exhibits antiviral activity against influenza virus. {ECO:0000269|PubMed:22106366}.;
Pathway
NOD-like receptor signaling pathway - Homo sapiens (human);Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Calcineurin-regulated NFAT-dependent transcription in lymphocytes;Interferon Signaling (Consensus)

Recessive Scores

pRec
0.0819

Intolerance Scores

loftool
0.899
rvis_EVS
3.02
rvis_percentile_EVS
99.23

Haploinsufficiency Scores

pHI
0.0601
hipred
N
hipred_score
0.112
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.435

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Gbp2b
Phenotype
growth/size/body region phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; digestive/alimentary phenotype;

Gene ontology

Biological process
defense response to virus;cellular response to interleukin-1;cellular response to tumor necrosis factor
Cellular component
Golgi membrane;cytoplasm;cytosol;perinuclear region of cytoplasm
Molecular function
GTPase activity;protein binding;GTP binding;protein homodimerization activity